Use careArticle link

Undiagnosed Dementia: How Common It Is, Who Is Missed, and What Detection Initiatives Are Underway

If you suspect a loved one has dementia but hasn’t received a formal diagnosis, you are not alone. Studies suggest that a significant number of older adults living with dementia in the community remain undiagnosed, and certain groups—including people from racial and ethnic minority backgrounds, those with lower education, and those without regular access to healthcare—are disproportionately affected. The good news is that researchers and community organizations are actively working to improve early and equitable detection through better screening tools, public awareness campaigns, and training for healthcare providers. This article will help you understand the scope of the problem, recognize who is most at risk of being missed, and learn what concrete steps you can take to advocate for a thorough evaluation.

Key points

  • Undiagnosed dementia is common: an estimated 40-80% of people with dementia in the community have never received a formal diagnosis.
  • Diagnostic disparities affect racial/ethnic minorities, people with lower education, and those without regular healthcare access.
  • Reversible conditions like depression, vitamin deficiencies, and medication side effects can mimic dementia—always rule these out first.
  • Mixed dementia (more than one type) is very common, especially in people over 85, but is often missed.
  • Early detection allows for better planning, access to treatments, and connection to support services.
  • You can advocate by tracking symptoms, requesting a thorough evaluation, and seeking a second opinion if needed.

How Common Is Undiagnosed Dementia?

Dementia is far more widespread than official diagnoses might suggest. Worldwide, an estimated 47 million people live with dementia, and that number is expected to rise to 131 million by 2050 (source 2). In the United States alone, over five million older adults have dementia, yet many of them have never received a formal diagnosis (source 20). Community-based studies indicate that a large proportion of people with dementia—perhaps as many as 40 to 80 percent—are undiagnosed or diagnosed only in the later stages of the disease (source 7). This gap means that countless individuals and their families are navigating cognitive decline without the support, resources, and planning that a diagnosis can provide.

Why does this happen? One major reason is that dementia is not a single disease but an umbrella term for many different conditions—Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed dementia (source 6). Because symptoms overlap and can be subtle at first, healthcare providers may initially attribute memory or thinking problems to normal aging, stress, or depression (source 9). Additionally, some doctors are hesitant to give a dementia diagnosis because they feel they cannot offer a cure, or they worry about causing distress (source 22). The U.S. Preventive Services Task Force has concluded that current evidence is insufficient to recommend routine screening for cognitive impairment in older adults, which means many cases are not caught early (source 8).

Who Is Affected by Diagnostic Disparities?

Diagnostic disparities are not random—they follow patterns of social and economic inequity. People from racial and ethnic minority groups, particularly Black and Hispanic older adults, are less likely to receive a timely dementia diagnosis compared to their white counterparts (source 1). Lower education levels, limited English proficiency, and living in rural or underserved areas also increase the risk of being missed (source 24). Furthermore, individuals with lower income may have less access to specialists, cognitive testing, and follow-up care (source 20). These inequities are compounded by the fact that many older adults do not receive appropriate sensory care—such as glasses or hearing aids—which can mimic or worsen cognitive symptoms and further delay diagnosis (source 21).

Another often-overlooked group is people with mixed dementia, meaning they have brain changes of more than one type (e.g., Alzheimer’s and vascular dementia). Mixed dementia is actually more common than previously recognized, especially in people over age 85, but it is frequently underdiagnosed because clinicians may stop looking after identifying one cause (sources 12, 18). Similarly, depression in older adults can look very much like dementia, and if depression goes untreated, it can accelerate cognitive decline (source 5). Many seniors with depression are never evaluated for dementia, or vice versa, leaving both conditions unaddressed.

What Detection Initiatives Are Underway?

Recognizing the scale of undiagnosed dementia, researchers and public health organizations are launching initiatives to improve early and equitable detection. One key approach is developing better screening tools that are culturally sensitive and can be used in primary care settings, not just specialty clinics (source 1). For example, brief cognitive assessments that take only a few minutes are being tested in community health centers and senior centers. Another strategy is training healthcare providers—from doctors to nurses to social workers—to recognize the early signs of dementia and to differentiate it from reversible conditions like medication side effects, vitamin B12 deficiency, or thyroid problems (source 3).

Community-based programs are also expanding. Organizations like the Alzheimer’s Association and local Area Agencies on Aging offer free memory screenings and educational workshops (source 22). Some initiatives focus on reaching underserved populations through churches, community centers, and mobile health units. Additionally, researchers are studying the role of sensory impairments—such as hearing loss—and whether treating them can improve cognitive outcomes or reveal underlying dementia earlier (source 21). While there is no national screening mandate yet, these grassroots efforts are helping to close the detection gap one community at a time.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

What not to do

  • Do not rely solely on a single brief memory test (e.g., Mini-Cog) for diagnosis—use comprehensive batteries

  • Do not dismiss symptoms as normal aging without objective cognitive testing

  • Do not assume a negative initial screening rules out dementia, especially in marginalized groups

  • Do not delay specialist referral while waiting for 'official' primary care diagnosis

Practical tools

  • Montreal Cognitive Assessment (MoCA)

    Validated for mild cognitive impairment and vascular dementia; available in multiple languages and literacy-adapted versions.

  • Rowland Universal Dementia Assessment Scale (RUDAS)

    Culturally fair test designed to minimize education and language bias, suitable for diverse populations.

  • Functional Activities Questionnaire (FAQ)

    Measures real-world functional decline (e.g., managing bills, cooking) to complement cognitive scores.

Discuss with your clinician

Ask your doctor: ‘Based on my loved one’s age, race, and medical history, are they at higher risk for being undiagnosed? What steps can we take to ensure a fair and accurate evaluation?’

If a diagnosis of Alzheimer’s is given, ask: ‘Should we consider a lumbar puncture or amyloid PET scan to confirm? These are not routine but may be available in research settings.’

If your loved one has a history of stroke or heart disease, ask: ‘Could this be vascular dementia or mixed dementia? Would an MRI of the brain help clarify?’

If depression is suspected, ask: ‘What is the safest antidepressant for someone with possible dementia? Some medications can worsen cognition.’

If your loved one is on multiple medications, ask: ‘Can we do a medication reconciliation and consider deprescribing any that might be affecting cognition?’

Related guides

Sources